In Vitro Approaches to Evaluate and Compare the Adhesion Performance of Transdermal and Topical Delivery Systems (TDS) (U01) Clinical Trial Required

Archived opportunity record

In Vitro Approaches to Evaluate and Compare t… is closed (last close March 31, 2022). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Wide-open applicant board · 14 Grants.gov doors

In Vitro Approaches to Evaluate and Compare t… prints 14 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +10 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Science and Technology / R&D (ST). 54 other Food and Drug Administration listings share this eligibility-code string (11% of 482).

Code 00

State governments

Code 01

County governments

Code 02

City or township governments

Code 04

Special district governments

Code 05

Independent school districts

Code 06

Public / state-controlled institutions of higher education

Code 07

Federally recognized tribal governments

Code 08

Public / Indian housing authorities

Code 11

Native American tribal organizations (other than Federally recognized tribal governments)

Code 12

Nonprofits with 501(c)(3) status (other than IHEs)

Code 13

Nonprofits without 501(c)(3) status (other than IHEs)

Code 20

Private institutions of higher education

Code 22

For-profit organizations other than small businesses

Code 23

Small businesses

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.